Standout Papers

Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia 2024 202668
  1. Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia (2024)
    Daniel Gaudet, Dénes Páll et al. JAMA Cardiology

Immediate Impact

1 from Science/Nature 56 standout
Sub-graph 1 of 23

Citing Papers

Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
2024 Standout
Cardiac Amyloidosis Due to Transthyretin Protein
2024 Standout
3 intermediate papers

Works of Karen Modesto being referenced

Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia
2024 Standout
Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques
2004

Author Peers

Author Last Decade Papers Cites
Karen Modesto 512 167 135 230 224 22 947
Sriram Sampath 100 259 98 136 60 33 1.2k
Giovanni Camastra 724 286 205 91 90 44 833
Amr M. Ajlan 238 400 126 327 219 42 884
Julia Schumm 739 265 261 163 70 27 1.1k
Yoshiki Matoba 760 158 200 126 93 28 1.1k
James M. Gulizia 214 27 201 316 119 19 880
John A. Greager 62 47 171 166 40 37 909
Jean–François Méritet 57 91 50 402 189 41 807
Roni Baruch 82 14 141 157 480 27 889
Isabelle Joris 87 32 139 169 85 27 1.0k

All Works

Loading papers...

Rankless by CCL
2026